Porter, "The role of avian reoviruses
in turkey tenosynovitis/arthritis," Avian Pathology, vol.
The recovery rate from paraffin samples is 20% or less for some DNA viruses such as adenoviruses (12); this number should be lower for RNA viruses such as reoviruses
, and this may account for the negative reovirus PCR results for 5 of the 6 birds tested.
citri Reovirus (DcRV) relationships with other reoviruses
, a phylogenetic tree was constructed by the neighbor-joining (NJ) methodology (Fig.
replicate in a large number of tissue culture systems of both primate and other animal origin and easily cause infection in laboratory animals making them good viruses for laboratory studies.
are ubiquitous in nature, infecting plants, animals and insects.
Pathogenicity and antigenic relatedness of several avian reovirus isolates: in vitro and in vivo characterization of avian reoviruses
. Avian Diseases, v.33, p.535-544, 1989.
(Calgary, Canada) has been granted United States Patent 7,163,678 entitled "Reovirus for the Treatment of Ral-Mediated Cellular Proliferative Disorders." The claims describe using recombinant reoviruses
for the treatment of Ral-mediated neoplasms and non-cancer cellular proliferative diseases such as neurofibromatosis.
For viral detection, the Carducci and co-authors recommended the reoviruses
because of their frequent presence.
The research to date on SARS indicates that it may be caused by two types of viruses that Burke predicted would be of great concern: coronaviruses and reoviruses
. The coronavirus may have come from an extremely rare recombination of viruses from mammal and bird hosts, wrote David Guttman, a University of Toronto professor of evolutionary genomics, in the January 2004 issue of the Journal of Virology.
that have been shown to be genetically distinct from chicken origin reoviruses
were isolated from commercial turkey flocks in the Southeastern US and Texas that were experiencing enteritis.
(Calgary, Canada) has been granted United States Patent 6,455,038 entitled "Reovirus for the treatment of cellular proliferative disorders." This patent covers the use of various strains and combinations of reoviruses
, wherein one or more of the reoviruses
may be immunoprotected, as a treatment for Ras-mediated proliferative disorders, such as neurofibromatosis and cancer in an immunocompetent mammal.
Sequence analysis showed that the 6 segments (L1-L3, M2, M3, and S3) of MRV1-HBA were closely related to those of the human MRV2tou05 strain and that the S1 and S2 segments were similar to those of other serotype 1 reoviruses
that infect humans.